title: [Regression during chemotherapy of lytic bone lesions in a patient with type B malignant non-Hodgkin's lymphoma].
authors.forename: E
authors.initials: E
authors.lastname: Pertuiset
authors.forename: V
authors.initials: V
authors.lastname: Leblond-Missenard
authors.forename: M
authors.initials: M
authors.lastname: Raphaël
authors.forename: J
authors.initials: J
authors.lastname: Gabarre
authors.forename: J L
authors.initials: JL
authors.lastname: Binet
authors.forename: M C
authors.initials: MC
authors.lastname: Dombret
mesh_terms: D000174:Acromion; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy*; D002968:Clavicle; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010014:Osteolysis / Q000188:drug therapy*
vernacular_title: Régression sous chimiothérapie des lésions osseuses lytiques dans un cas de lymphome malin non hodgkinien de type B.